,
Abad-Arranz, María
Moran-Rodríguez, Ana
Mascarós Balaguer, Enrique
Quintana Velasco, Carmen
Abad Polo, Laura
Núñez Palomo, Sara
Gonzálvez Rey, Jaime
Fernández Vargas, Ana María
Hidalgo Requena, Antonio
Helguera Quevedo, Jose Manuel
García Pardo, Marina
Lopez-Campos, Jose Luis http://orcid.org/0000-0003-1703-1367
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Received: 24 October 2017
Accepted: 20 June 2018
First Online: 3 July 2018
Ethics approval and consent to participate
: The study was evaluated by the Spanish Agency for Medicine and Health Products and classified as a not post-commercialization observational study. This study was approved by the regional ethical committee of Andalusia at Hospital Universitario Virgen del Rocio (approval number 02/2014). Because of the retrospective nature of the study, the anonymization of data, and the lack of active research interventions, the need for informed consent was waived. The ethics committee was aware of these circumstances clearly explained in the protocol, and approved this procedure.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.